Search clinical trials for: Sevelamer Carbonate (Renvela)

Total 928 results

Tel-Aviv Sourasky Medical Center
Genzyme, a Sanofi Company; Wolfson Medical Center

Completed

Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease (SUMMER)

Hemodialysis | End Stage Renal Disease | Intimal Media Thickness

Israel
Azienda Sanitaria ASL Avellino 2

Completed

Reduce Cardiovascular Calcifications to Reduce QT Interval in Dialysis (Independent)

Cardiovascular Mortality

Italy
Akebia Therapeutics

Completed

Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

Healthy Volunteers

Canada
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, Belgium, Croatia, Austria, Czech Republic, Germany, Lithuania, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
Karolinska Institutet
Göteborg University

Withdrawn

Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) (SIR)

Insulin Resistance | Kidney Failure, Chronic | End-Stage Renal Disease | Hyperphosphatemia

Sweden
Long Island University
California State University, Los Angeles

Completed

Effects of Novel Sodium Bicarbonate Ingestion of Buffering Capacity

PERFORMANCE-ENHANCING EFFECT
The University of Hong Kong

Unknown

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

AML | FLT3-ITD Mutation

Hong Kong
University of Nove de Julho
Marcelo Martins Kalytczak

Unknown

Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task

Fatigue | Electromyography | Sodium Bicarbonate | Alkalosis, Metabolic

Brazil
National Cancer Institute (NCI)

Completed

Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Childhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
Genzyme, a Sanofi Company

Completed

Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing

Chronic Kidney Disease

United States
The University of Texas Health Science Center at...
American Diabetes Association

Completed

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1) (MicroB1)

Insulin Sensitivity

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
David P. Richman, MD
Jacobus Pharmaceutical

No longer available

Treatment of Lambert-Eaton Syndrome With 3,4 DAP

Lambert Eaton Myasthenic Syndrome

United States
Astellas Pharma Inc

Completed

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Chronic Kidney Disease | Hyperphosphatemia

Japan
University of Sao Paulo

Completed

Consistencies in Responses to Sodium Bicarbonate?

Sports Nutritional Physiological Phenomena

Brazil
Ineos Healthcare Limited

Completed

Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia (ACT3)

Chronic Kidney Failure

United Kingdom
Amgen Research (Munich) GmbH

Completed

A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)

Healthy Volunteers
Novartis Pharmaceuticals

Completed

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis (SBR759)

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

Germany, United Kingdom, Italy, Belgium, Sweden, Canada, United States, Australia, Finland, France, Norway, Puerto Rico, Switzerland
Ineos Healthcare Limited

Terminated

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride

Chronic Kidney Failure

United States, Italy, Brazil, Belgium, United Kingdom, Estonia, Bulgaria, Serbia, Israel, Czech Republic, Hungary, Lithuania, Mexico, Slovakia, South Africa
Shire

Completed

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Kidney Failure, Chronic
Shire

Completed

Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis

Kidney Failure, Chronic
Shire

Completed

Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood

Kidney Failure, Chronic
Astellas Pharma Inc

Completed

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Renal Insufficiency | Chronic Kidney Disease | Renal Dialysis

Japan
The University of Hong Kong

Completed

Sevelamer Hydrochloride in Peritoneal Dialysis Patients (SERENE)

Endstage Renal Disease

Hong Kong
University of Illinois at Chicago
Shire

Completed

Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients

Hyperphosphatemia | Kidney Disease

United States
University Hospital, Gentofte, Copenhagen
Sanofi

Completed

Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion

Diabetes Mellitus, Type 2

Denmark
Novartis Pharmaceuticals

Completed

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis (SBR759)

Chronic Kidney Disease

Taiwan, Japan
Shire

Completed

Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

End Stage Renal Disease

United States
Bayer

Completed

Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

Clinical Pharmacology

Japan
Bayer

Completed

Bioequivalence Study of BAY77-1931 Granule

Hyperphosphatemia

Japan
Shire

Completed

Long-term Effect of Lanthanum Carbonate on Bone

Hyperphosphatemia

United States, Germany, United Kingdom
Cristália Produtos Químicos Farmacêuticos Ltda.

Completed

Efficacy and Safety of Lodenafil Carbonate in the Treatment of Erectile Dysfunction in Patients With Diabetes.

Erectile Dysfunction

Brazil
Universitair Ziekenhuis Brussel

Recruiting

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis (LaCa)

Nephrolithiasis | Secondary Hyperoxaluria

Belgium
Shire

Completed

A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.

Kidney Failure, Chronic
Shire

Completed

Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease

Kidney Diseases

United States
Bayer

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Hyperphosphatemia | Dialysis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia

France, Poland, United Kingdom, Spain, South Africa, Australia, Czech Republic, Germany, Hungary, Italy, Austria
Mitsubishi Tanabe Pharma Corporation

Completed

A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia | Dialysis

France, Poland, Ukraine, United Kingdom, Spain, Serbia, South Africa, Russian Federation, Czech Republic, Germany, Hungary, Italy, Austria, Macedonia, The Former Yugoslav Republic of, Malaysia
Unicycive Therapeutics, Inc

Active, not recruiting

A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis

Chronic Kidney Disease Requiring Chronic Dialysis

United States
Lundquist Institute for Biomedical Innovation at...

Completed

Fosrenol and Phosphorus Balance - Lanthanum Carbonate

End-stage Renal Disease | Chronic Kidney Failure | Disorders Associated With Peritoneal Dialysis

United States
Shire

Terminated

Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5

Kidney Diseases

Netherlands, Germany, Austria, Belgium, Denmark, Italy
University Hospital, Gentofte, Copenhagen
Sanofi

Completed

Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota

Type 2 Diabetes

Denmark
Shire

Completed

Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD

Chronic Kidney Disease

France
University of Illinois at Chicago
Shire

Completed

Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate

Hyperphosphatemia in Chronic Kidney Disease

United States
Bayer

Completed

Fosrenol Post-marketing Surveillance in Japan

Hyperphosphatemia | Kidney Disease

Japan
Astellas Pharma Inc
FibroGen

Completed

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

Healthy Subjects

Japan
Bayer

Completed

Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients

Hyperphosphatemia

Japan
Bayer
Shire

Completed

Study in Chronic Kidney Disease (CKD) Not on Dialysis

Hyperphosphatemia

Japan
National Institute of Diabetes and Digestive and...

Completed

Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer

Thyroid Cancer | Differentiated Thyroid Carcinoma

United States
Bayer
Shire

Completed

Long-term Study in Chronic Kidney Disease (Extension From Study 14817)

Hyperphosphatemia

Japan

Search clinical trials for: Sevelamer Carbonate (Renvela)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations